Cidara Therapeutics, Inc. — Investor Relations & Filings
Cidara Therapeutics, Inc. is a biotechnology company that develops targeted immunotherapies and novel anti-infectives for patients with serious diseases. The company utilizes its proprietary Cloudbreak® platform to create drug-Fc conjugates (DFCs). These DFCs are engineered as 'single molecule cocktails' by coupling targeted small molecules or peptides to a human antibody fragment (Fc). This approach is designed to directly inhibit disease targets, such as fungal or viral pathogens, while simultaneously engaging the patient's immune system. The company's focus is on developing therapies for the treatment and prevention of life-threatening infections and other serious conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| SCHEDULE 13G Filing | 2026-01-30 | English | |
| Regulatory Filings 2026 | 2026-01-12 | English | |
| Regulatory Filings 2026 | 2026-01-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 30910938 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30910864 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30910905 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 30910876 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 12788824 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788825 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788826 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788827 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788828 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788829 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788830 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12788831 | Major Shareholding Notification 2026 | 2026-01-09 | English | ||
| 12788832 | FORM 4 | 2026-01-08 | English | ||
| 12788833 | FORM 4 | 2026-01-08 | English | ||
| 12788834 | FORM 4 | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Cidara Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31535/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31535 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31535 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31535 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31535}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cidara Therapeutics, Inc. (id: 31535)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.